Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 17.06 HKD -1.04% Market Closed
Market Cap: 37.3B HKD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Genscript Biotech Corp

Wall Street analysts forecast Genscript Biotech Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Genscript Biotech Corp is 24.66 HKD with a low forecast of 21.64 HKD and a high forecast of 30.19 HKD.

Lowest Forecast
Wall Street Target
21.64 HKD
27% Upside
Average Forecast
Wall Street Target
24.66 HKD
45% Upside
Highest Forecast
Wall Street Target
30.19 HKD
77% Upside
Lowest
Price Target
21.64 HKD
27% Upside
Average
Price Target
24.66 HKD
45% Upside
Highest
Price Target
30.19 HKD
77% Upside
Genscript Biotech Corp Competitors:
Price Targets
BANB
Bachem Holding AG
19% Upside
N
NANOFH
Nanoform Finland Oyj
226% Upside
DIVISLAB
Divi's Laboratories Ltd
4% Upside
O
688238
Obio Technology Shanghai Corp Ltd
34% Upside
BANB
Bachem Holding AG
19% Upside
N
NANOFH
Nanoform Finland Oyj
226% Upside
DIVISLAB
Divi's Laboratories Ltd
4% Upside
O
688238
Obio Technology Shanghai Corp Ltd
34% Upside
1521
Frontage Holdings Corp
10% Downside
MRVI
Maravai LifeSciences Holdings Inc
56% Upside
WST
West Pharmaceutical Services Inc
26% Upside
M
MXCT
MaxCyte Inc
326% Upside

Revenue
Forecast

Revenue Estimate
Genscript Biotech Corp

For the last 11 years the compound annual growth rate for Genscript Biotech Corp's revenue is 23%. The projected CAGR for the next 3 years is 17%.

23%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Genscript Biotech Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Genscript Biotech Corp

For the last 11 years the compound annual growth rate for Genscript Biotech Corp's net income is 76%. The projected CAGR for the next 3 years is -55%.

76%
Past Growth
-55%
Estimated Growth
Estimates Accuracy
-27%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Genscript Biotech Corp's stock price target?
Price Target
24.66 HKD

According to Wall Street analysts, the average 1-year price target for Genscript Biotech Corp is 24.66 HKD with a low forecast of 21.64 HKD and a high forecast of 30.19 HKD.

What is Genscript Biotech Corp's Revenue forecast?
Projected CAGR
17%

For the last 11 years the compound annual growth rate for Genscript Biotech Corp's revenue is 23%. The projected CAGR for the next 3 years is 17%.

What is Genscript Biotech Corp's Net Income forecast?
Projected CAGR
-55%

For the last 11 years the compound annual growth rate for Genscript Biotech Corp's net income is 76%. The projected CAGR for the next 3 years is -55%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 283,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.